- Tytuł:
-
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with
mild cognitive impairment ormild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial. - Autorzy:
- Źródło:
- Trials. 3/4/2024, Vol. 25 Issue 1, p1-20. 20p.
Czasopismo naukowe